Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniela Rožková"'
Autor:
Michal Hensler, Jana Rakova, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Peter Holicek, Marek Hraska, Tereza Hrnciarova, Pavla Kadlecova, Andreu Schoenenberger, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Jana Drozenova, Jan Laco, Rudolf Horvath, Michal Podrazil, Guo Hongyan, Tomas Brtnicky, Michal J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, Abhishek D. Garg, David Cibula, Jirina Bartunkova, Radek Spisek, Jitka Fucikova
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Dendritic cells (DCs) have received considerable attention as potential targets for the development of novel cancer immunotherapies. However, the clinical efficacy of DC-based vaccines remains suboptimal, largely reflecting local and systemic immunos
Externí odkaz:
https://doaj.org/article/8aa6cc35d16f49fbb0529e5fcefe2e0f
Autor:
Jirina Bartůnková, Daniela Seifertová, Zuzana Tobiasova, Dagmar Pospisilova, Daniela Rožková, Jan Stary, Jiřina Borovičková, Radek Spisek
Publikováno v:
Medical Oncology. 22:079-088
Cell immunotherapy through dendritic cells (DC) presents a hopeful strategy for the treatment of various tumors. The aim of our study was to find which progenitor cells are most suitable for the preparation of dendritic cells in acute lymphoblastic l
Autor:
Andrea Poloučková, Radek Spisek, Petr Sedlacek, Rudolf Horvath, Daniela Rožková, J Lašťovička, Anna Sediva
Summary Hyper-immunoglobulin (Ig)E syndrome (HIES) is a primary immunodeficiency associated with mutations in STAT3 resulting in impaired development of T helper type 17 (Th17) lymphocytes. HIES patients with a reduced frequency of Th17 cells present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e90cb82e729f3d6eef6283e2f526213
https://europepmc.org/articles/PMC3193916/
https://europepmc.org/articles/PMC3193916/
Autor:
Jiřina Bartůňková, Vít Budinský, Zuzana Tobiasova, Daniela Rožková, Radek Spisek, Sylvie Dusilová-Sulková, Klara Sochorova
Publikováno v:
Clinical immunology (Orlando, Fla.). 133(1)
Paricalcitol (19-nor-1,25/OH(2)/D(2)), a second generation vitamin D receptor (VDR) activator, is a synthetic analogue of vitamin D3. In contrast to calcitriol, paricalcitol has a reduced effect on intestinal calcium resorption thus avoiding undesira
Autor:
Vít Budinský, Radek Spisek, Jiřina Bartůňková, Klara Sochorova, Daniela Rožková, Kateřina Pokorná, Jitka Fucikova, Hana Ulcová
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 9, Iss 1, p 223 (2011)
Journal of Translational Medicine, Vol 9, Iss 1, p 223 (2011)
Background For clinical applications, dendritic cells (DCs) need to be generated using GMP-approved reagents. In this study, we tested the characteristics of DCs generated in two clinical grade culture media and activated by three maturation stimuli,